Please wait...

Learn

Finding accredited CPD

CAR-T cell therapy Research Review Issue 4

Description

CAR-T cell therapy Research Review Issue 4 with commentary by Dr Salvatore (Sam) Fiorenza.

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in CAR-T Cell Therapy. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

Details

In this edition we feature:
-  Weight loss before CAR T-cell therapy
-  Siltuximab for CRS and ICANS
-  Addition of nivolumab to CAR-T cells
-  GPC3 CAR-T cells co-expressing IL-15
-  Tolerability of IV autologous GD2-CAR T cells
-  Efficacy of CD5-gene-edited CAR-T cell therapy
-  TRBC1-directed autologous CAR-T cells
-  Occurrence of late AEs
-  Impact of broad-spectrum antibiotics
-  Survival outcomes of DHL and DEL DLBCL

To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide.

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.

Provided by

CPD Activity Details

Topic

Haematologic Diseases

CAPE Aspects

Effective Year

Educational Activities (EA) - 0.30

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.